Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 2

Conditions

Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma 2Leukemia 2Infections 2Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 10Etoposide 6Doxorubicin 6Cytarabine 6Prednisone 5Vincristine 4Trimethoprim, Sulfamethoxazole Drug Combination 4Methotrexate 4gamma-Globulins 3Rituximab 3Radiotherapy 3Filgrastim 3Ciprofloxacin 3pegaspargase 2nelarabine 2etoposide phosphate 2calaspargase pegol 2Triptorelin Pamoate 2Thioguanine 2Prednisolone 2Methylprednisolone 2Mercaptopurine 2Melphalan 2Magnetic Resonance Spectroscopy 2Immunoglobulins, Intravenous 2Dexamethasone 2Daunorubicin 2Cyclosporine 2Calcium Dobesilate 2Bortezomib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Lymphoma × Immunoglobulins, Intravenous × Clear all
NCT07202052 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms, Plasma Cell

NCT07202065 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡